{"disease":{"id":"relapsed-malt-type-extranodal-marginal-zone-b-cell-lymphoma","name":"relapsed malt type extranodal marginal zone b cell lymphoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04604028","title":"Lenalidomide and Low-dose Cyclophosphamide for MALT Lymphoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":21,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}